Marc Goodman

Stock Analyst at Leerink Partners

(2.53)
# 682
Out of 5,344 analysts
142
Total ratings
58.73%
Success rate
29.16%
Average return
40 Stocks
Name Action PT Current % Upside Ratings Updated
AMLX Amylyx Pharmaceutica...
Upgrades: Outperform
4 10
4.71 112.31% 5 May 7, 2025
OPT Opthea
Downgrades: Market Perform
12 1
n/a n/a 2 Mar 25, 2025
AXSM Axsome Therapeutics
Maintains: Outperform
110 150
103.99 44.24% 7 Feb 10, 2025
RLMD Relmada Therapeutics
Downgrades: Market Perform
10 1
0.66 51.52% 3 Dec 4, 2024
BHVN Biohaven
Maintains: Outperform
55 60
15.34 291.13% 6 Sep 23, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
32
29.35 9.03% 1 Apr 15, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
25
61.62 -59.43% 1 Jul 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
1
n/a n/a 5 Mar 1, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
50
13.19 279.08% 1 Jan 30, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 23
n/a n/a 4 Jan 23, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
18 20
9.8 104.08% 3 Jan 19, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
15 1
n/a n/a 4 Nov 15, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
100 115
122.59 -6.19% 4 Nov 2, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
270 310
128.28 141.66% 11 Oct 26, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
9 4
n/a n/a 4 Aug 16, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
6 12
9.05 32.6% 2 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
40 46
29.47 56.09% 4 Aug 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
170 270
n/a n/a 2 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
27 21
22.18 -5.32% 5 Aug 9, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
200 210
109.46 91.85% 5 Aug 4, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
50 40
6.53 512.56% 5 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
15 10
1.68 495.24% 2 Jul 11, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Market Perform
24 27
29.89 -9.67% 5 Apr 28, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
65 70
n/a n/a 3 Apr 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
10 2
n/a n/a 4 Mar 3, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
24 15
2.19 584.93% 2 Dec 21, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Outperform
37 32
n/a n/a 3 Dec 20, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
322 70
n/a n/a 3 May 13, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Market Perform
200 220
n/a n/a 1 Feb 4, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
300 270
421.34 -35.92% 5 Mar 13, 2020
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
79 96
185.44 -48.23% 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
189 203
n/a n/a 5 Nov 19, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
72 0
n/a n/a 2 May 21, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 3 Nov 13, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
6 7
n/a n/a 4 Nov 10, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Sell
12 16
n/a n/a 2 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
72 67
77.48 -13.53% 3 Oct 30, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 15
n/a n/a 2 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
84 98
27.32 258.71% 3 Oct 5, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 1 Mar 20, 2017